ERYTECH announces management change Post author:admERY Post published:January 8, 2015 Post category:Newsroom ERYTECH today announced that Pierre-Olivier Goineau will be leaving the company to pursue other interests. You Might Also Like ERYTECH business update and financial results for the first half of 2013 August 28, 2013 ERYTECH Announces Results from TRYbeCA-1 Phase 3 Trial of Eryaspase in Patients with Second-line Advanced Pancreatic Cancer October 25, 2021 ERYTECH positions its lead product in solid tumors and launches a Phase II clinical study in pancreatic cancer January 7, 2014
ERYTECH Announces Results from TRYbeCA-1 Phase 3 Trial of Eryaspase in Patients with Second-line Advanced Pancreatic Cancer October 25, 2021
ERYTECH positions its lead product in solid tumors and launches a Phase II clinical study in pancreatic cancer January 7, 2014
